QT
KRYS icon

Quantamental Technologies’s Krystal Biotech KRYS Stock Holding History

Quantamental Technologies’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,900
Closed -$223K – 454
2023
Q2 		$223K Buy
+1,900
New +$194K 0.09% 370

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Quantamental Technologies's KRYS Position: Q3 2023 in Review

Quantamental Technologies sold out of Krystal Biotech (KRYS) in Q3 2023, closing a stake of 1,900 shares — an estimated $223K sold.

Quantamental Technologies first reported a position in KRYS in Q2 2023 and held it in 1 quarter. The position peaked at $223K in Q2 2023. 188 funds tracked by Wall St. Rank hold KRYS as of Q3 2023.

  • Quantamental Technologies reported no remaining Krystal Biotech position as of Q3 2023 after selling out during the quarter.
  • Quantamental Technologies sold 1,900 Krystal Biotech shares in Q3 2023, an estimated $223K.
  • Quantamental Technologies first reported a position in Krystal Biotech in Q2 2023 and held it in 1 quarter.
  • Quantamental Technologies's Krystal Biotech position peaked at $223K in Q2 2023.
  • 188 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.